- Location
marketing rights
"-
Chinese Sports Industry Was Booming in 2016
Dec 26, 2016Keeping up a sound and steady pace of development, the Chinese sports industry was booming in 2016 as investors tried to cover a wider range of business, while finding new engines to drive growth. Policy-oriented industry China's State ...
Tags: Sports Industry, outdoor sports
-
Frutarom Takes 50% Stake in Algalo to Fortify Algae-Based Products Portfolio
Feb 6, 2016Israel-based ingredients company Frutarom has acquired 50% stake in Algalo Industries to fortify its position in algae-based products segment. Frutarom has invested NIS10m ($2.6m) to acquire the stake. As part of its growth strategy, ...
Tags: Frutarom, algae-based products
-
Under Armour Has Signed a Multi Year Partnership with Rugby Club
May 11, 2015Performance apparel, footwear and accessories marketer Under Armour has signed a multi year partnership with rugby club, Wasps and has become the club’s official technical wear partner. According to a Wasps press release, it ...
Tags: Performance apparel, footwear
-
Puma and The Italian Football Federation Announced a New Comprehensive Partnership
Mar 31, 2015Puma and The Italian Football Federation (FIGC) announced a new comprehensive partnership that will see Puma operate as the FIGC’s lead partner into the next decade. Through this agreement, Puma has extended and increased its ...
-
Distell Is in Negotiations to Acquire a Few of Tilaknagar Industries's Brands
Mar 25, 2015Distell Group, a leading liquor producer in South Africa, is in negotiations with India-based Tilaknagar Industries to acquire a few of latter’s brands. Tilaknagar Industries, which has INR 8bn- ($128m) debt, expects to generate ...
Tags: Distell Group, Liquor, Food
-
The Afrezza-Branded Inhaled Insulinwill Be Introduced in The U.S
Aug 15, 2014The Afrezza-branded inhaled insulin from Mannkind (Valencia, CA) will be introduced in the United States in 2015 after Sanofi entered into an agreement with the company, offering up to $925 million for the rights to sell the product ...
-
Cerana Beverages Has Raised Funding From Private Investors
Jun 26, 2014Indian craft beer firm Cerana Beverages has raised funding from private investors, in a move to launch its craft beer brand – Biru, across the country. Cerana's proposed packaged craft beer brand will be available in top cities, ...
-
Concentrate Produced at Sydvaranger Was Being Trialed at Further Sinter Plants in Europe
Apr 3, 2014Norway-focused iron ore miner Northern Iron said Tuesday concentrate produced at Sydvaranger was being trialed at further sinter plants in Europe, after inaugural cargoes were bought by ArcelorMital and ThyssenKrupp in 2013. Northern Iron ...
-
The U.S. Food and Drug Administration (FDA) Has Approved The New Drug Application
Jan 17, 2014Mallinckrodt (NYSE: MNK) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for PENNSAID® (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal ...
-
Bayer HealthCare Has Submitted VEGF Trap-Eye for Regulatory Approval in Japan
Dec 5, 2013Bayer HealthCare has submitted VEGF Trap-Eye (aflibercept solution for injection) for regulatory approval in Japan to treat patients with myopic choroidal neovascularization (myopic CNV), one of the most common causes of eye disease. In ...
-
The FDA Has Approved Nexavar for The Treatment of Locally Recurrent or Metastatic
Nov 26, 2013Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...
-
Bayer and Regeneron Pharmaceuticals Are Collaborating on The Global Development of Eylea
Nov 26, 2013Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Bayer HealthCare's Eylea (aflibercept, solution for intravitreal injection) for the treatment of macular edema secondary to central retinal vein occlusion (CRVO). In ...
-
Alcon Has Launched Jetrea to Treat Symptomatic Vitreomacular Adhesion
Nov 25, 2013Belgium-based biopharmaceutical firm ThromboGenics has announced that its partner Alcon has launched Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA) in Canada. According to the company, Canada is the ...
Tags: Alcon, Vitreomacular Adhesion
-
Ignyta Has Entered Into a License Agreement with Nerviano Medical Sciences
Nov 6, 2013US-based biotechnology firm Ignyta has entered into a license agreement with Nerviano Medical Sciences (Nerviano), under which Ignyta will get exclusive global development and marketing rights of tyrosine kinase inhibitors RXDX-101 and ...
Tags: Ignyta, Tyrosine Kinase Inhibitors
-
US FDA's Antiviral Drugs Advisory Committee Has Recommended Approval
Oct 28, 2013The US FDA's Antiviral Drugs Advisory Committee has recommended approval for Medivir's investigational protease inhibitor simeprevir (TMC435) 150mg capsules for the treatment of genotype 1 chronic hepatitis C in adult patients with ...
Tags: Medivir, Hepatitis C Patients